McGarry; Daniel G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McGarry; Daniel G..The latest application filed is for "1, 3, 4-oxadiazol-2-ones as ppar delta modulators and their use thereof".

Company Profile

0.13.9

McGarry; Daniel G. - Branchburg NJ
McGarry; Daniel G. - King of Prussia PA
McGarry, Daniel G. - Bedminster NJ
McGarry; Daniel G. - Bedminister NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereof Grant 7,872,032 - McGarry , et al. January 18, 2	2011-01-18
Heterocyclic compounds as P2X7 ion channel blockers Grant 7,741,493 - Shum , et al. June 22, 2	2010-06-22
Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonists Grant 7,709,509 - Keil , et al. May 4, 2	2010-05-04
1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease Grant 7,638,539 - McGarry , et al. December 29, 2	2009-12-29
1, 3, 4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof App 20090275621 - MCGARRY; Daniel G. ; et al.	2009-11-05
1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof Grant 7,576,109 - McGarry , et al. August 18, 2	2009-08-18
Therapeutic uses of di-aryl acid derivatives Grant RE40,558 - Jayyosi , et al. October 28, 2	2008-10-28
Methods For The Treatment Of Metabolic And Glucose Utilization Disorders Through The Administration Of Oxadiazolones And Derivatives Thereof As Peroxisome Proliferator - Activated Receptor (ppar) Delta Agonists App 20080262052 - KEIL; Stefanie ; et al.	2008-10-23
Heterocyclic Compounds As P2x7 Ion Channel Blockers App 20080132550 - SHUM; Patrick ; et al.	2008-06-05
Heterocyclic compounds as P2X7 ion channel blockers Grant 7,326,792 - Shum , et al. February 5, 2	2008-02-05
Oxadiazolones And Derivatives Thereof As Ppar Delta Agonists App 20070179191 - KEIL; Stefanie ; et al.	2007-08-02
1, 3, 4-oxadiazol-2-ones As Peroxisome-proliferator Activated Receptor Delta Modulators And Their Use In The Treatment Of Neurological And Metabolic Disease App 20070099964 - McGarry; Daniel G. ; et al.	2007-05-03
1,3,4-oxadiazol-2-ones As Ppar Delta Modulators And Their Use Thereof App 20070060626 - MCGARRY; Daniel G. ; et al.	2007-03-15
Therapeutic uses of tri-aryl acid derivatives Grant 7,005,440 - Jayyosi , et al. February 28, 2	2006-02-28
Heterocyclic compounds as P2X7 ion channel blockers App 20050026916 - Shum, Patrick ; et al.	2005-02-03
Therapeutic uses of di-aryl acid derivatives Grant 6,635,655 - Jayyosi , et al. October 21, 2	2003-10-21
Substituted (aminoiminomethyl or aminomethyl) benzoheteroaryl compounds App 20030153604 - Dankulich, William P. ; et al.	2003-08-14
Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans Grant 6,599,918 - Burns , et al. July 29, 2	2003-07-29
Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans App 20020193410 - Burns, Christopher J. ; et al.	2002-12-19
Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides Grant 6,323,227 - Klein , et al. November 27, 2	2001-11-27
Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds Grant 6,034,093 - Ewing , et al. March 7, 2	2000-03-07
Aromatic oligomeric compounds useful as mimics of bioactive macromolecules Grant 5,571,506 - Regan , et al. November 5, 1	1996-11-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.